Adlai Nortye (ANL) Enterprise Value (2022 - 2025)
Adlai Nortye's (ANL) quarterly Enterprise Value came in at -$8.1 million in Q4 2025, up 86.77% year-on-year from -$4.3 million in Q4 2024, and up 81.75% on a QoQ basis from -$44.1 million in Q2 2025.
Adlai Nortye (ANL) Enterprise Value (2022 - 2025) Analysis & Trends
Adlai Nortye (ANL) has 4 years of Enterprise Value data on file, last reported at -$8.1 million in Q4 2025.
- On a quarterly basis, Enterprise Value rose 86.77% year-over-year to -$8.1 million in Q4 2025; TTM through Dec 2025 was -$8.1 million, a 86.77% increase from a year earlier, with the FY2025 full-year figure at -$8.1 million, up 86.77% from the prior year.
- Enterprise Value for Q4 2025 stood at -$8.1 million, up from -$44.1 million in the prior quarter.
- Over the last five years, Enterprise Value for ANL reached as high as -$8.1 million in Q4 2025 and fell as low as -$98.0 million in Q2 2024.
- Historically, Enterprise Value has averaged -$61.1 million across 4 years, with a median of -$62.5 million in 2022.
- Across the five-year window, Enterprise Value sank 42.87% in 2023 and soared 86.77% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$64.0 million in 2022, then sank by 42.87% to -$91.5 million in 2023, then soared by 33.43% to -$60.9 million in 2024, then surged by 86.77% to -$8.1 million in 2025.
- Per Business Quant data, the three most recent Enterprise Value figures were -$8.1 million in Q4 2025, -$44.1 million in Q2 2025, and -$60.9 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 472.03 Bn | 467.24 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 122.09 Bn | 114.84 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.99 Bn | 50.80 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Adlai Nortye | 1.19 Bn | 1.18 Bn | - | -8.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.06 Mn |
| Jun 30, 2025 | -44.15 Mn |
| Dec 31, 2024 | -60.91 Mn |
| Jun 30, 2024 | -97.99 Mn |
| Dec 31, 2023 | -91.50 Mn |
| Dec 31, 2022 | -64.05 Mn |